ABSTRACT The completion of the Anopheles gambiae Giles genome sequencing project is a milestone toward developing more effective strategies in reducing the impact of malaria and other vector borne diseases. The successes in developing transgenic approaches using mosquitoes have provided another essential new tool for further progress in basic vector genetics and the goal of disease control. The use of transgenic approaches to develop refractory mosquitoes is also possible. The ability to use genome sequence to identify genes, and transgenic approaches to construct refractory mosquitoes, has provided the opportunity that with the future development of an appropriate genetic drive system, refractory transgenes can be released into vector populations leading to nontransmitting mosquitoes. An. gambiae populations incapable of transmitting malaria. This compelling strategy will be very difÞcult to achieve and will require a broad substantial research program for success. The fundamental information that is required on genome structure, gene function and environmental effects on genetic expression are largely unknown. The ability to predict gene effects on phenotype is rudimentary, particularly in natural populations. As a result, the release of a refractory transgene into natural mosquito populations is imprecise and there is little ability to predict unintended consequences. The new genetic tools at hand provide opportunities to address an array of important issues, many of which can have immediate impact on the effectiveness of a host of strategies to control vector borne disease. Transgenic release approaches represent only one strategy that should be pursued. A balanced research program is required.
THE COMPLETION OF THE PROJECT to sequence the Anopheles gambiae Giles genome represents an important milestone in mankindÕs continuing battle against vector borne diseases. The availability of this information will be an essential tool to understanding this important vector of human misery and will be invaluable to other studies aimed at understanding a variety of other mosquito species, and other arthropods. This is amply laid out with great excitement in the several articles announcing the completion of the genome project in Science magazine (Science vol. 298, 4 October 2002) . The information published in this issue about the structure of the An. gambiae genome based solely on the sequence information is astounding.
Amid the shared and justiÞed exuberance generated by the completion of the project, there is a need for a realistic appraisal on what the An. gambiae genome sequence means to mankindÕs ability to move forward with the ultimate goal of reducing the impact of malaria and other vector borne diseases. Medical entomologists recognize that the genome sequence is a Þrst step. The completion of this particular sequencing project may be the easiest part of the processÑ albeit a technical tours de force. There is hope, as Dorothy believed in her trek to see the Wizard of Oz; we are on the "yellow brick" road at last. Indeed we are, but we are at the very beginning.
Skeptics have viewed some genome sequencing efforts as an independent enterprise separated from any actual impact to answer speciÞc issues in biology. The skeptics might say this is in part the result of the technical success of the human genome sequencing project and the investment in the infrastructure to provide sequence information that was made in support of that project. This project provided funds and support of many sequence workers and expensive sequencing machines now stand ready and awaiting more work. The availability of this technology and ready infrastructure has resulted in a line up of organisms, prioritized, and awaiting sequence. Medical entomologists are certainly pleased with the choice of An. gambiae. The Þeld would have been pleased with any of the major vectors in Aedes or Culex as well. No one is likely to criticize the choice of An. gambiae given its role and impact as a vector of so much human disease in the world. The challenge will be to use sequence information as a tool to effectively increase our understanding of An. gambiae and other mosquito vectors, and to reduce the impact of mosquito borne disease.
The Goals of Mosquito Genome Sequencing and Transgenics
In the case of An. gambiae, several goals were the basis of the justiÞcation for the genome sequence project and why it was essential to have this species among the Þrst organisms to be sequenced. For medical entomology, these goals have been part of our dreams for the future for more then 30 yrÑstarting from the early days of characterizing mosquito genetics using morphological traits, to the Þrst studies using isozyme and protein electrophoretic techniques. The general goals remain todayÑ different technology, the same goals:
1. To provide understanding of mosquito biology, i.e., vector-pathogen-host interactions, and life history.
To identify the determinants of important vector phenotypes, i.e., insecticide resistance, behaviors, the traits comprising vector competence and capacity, i.e., what controls the ability of An. gambiae to transmit malaria to humans so efÞciently? 2. To characterize the ability of natural mosquito populations to transmit vector borne pathogens and develop strategies to interfere with this ability, i.e., release refractory mosquitoes to replace susceptible mosquitoes and reduce transmission. Releasing transgenic mosquitoes are among the recent possible methods to accomplish this. 3. To develop strategies using genetics to reduce mosquito population sizes below thresholds resulting in lowering the risk for human disease, i.e., a simplistic view of fewer An. gambiae, less malaria.
Participants at one workshop identiÞed three primary goals that needed to be met before a transgenic release control strategy could be Þeld-tested. These were listed in a WHO/TDR summary of this meeting (Prospects for Malaria Control by Genetic Manipulation of Its Vectors, TDR/BCV/MAL-ENT/91.3, World Health Organization, Geneva, 1991). These relate to the second and third goals I have listed above and were:
1. The development of genetic engineering tools that could be used with malaria vectors. 2. The identiÞcation of effector genes that could block parasite transmission. 3. The development of effective methods to drive these effector genes to Þxation in natural populations Several articles in the 4 October Science (Alphey et al. 2002 , Morel et al. 2002 state the successes reported in several studies that lead to the pronouncement that the Þrst two aims of the workshop have been largely achieved. There has been successful genetic transformation in both Anopheles (Catteruccia et al. 2000 , Grossman et al. 2001 and Aedes ). There has also been identiÞ-cation of effector genes that inßuence parasite development in Anopheles (Lowenberger et al. 1998 , as well as in other mosquito species (see Beerntsen et al. 2000) . The success in achieving these two aims has led to discussions to begin focusing on studies to address the remaining problem identiÞed in the workshop to develop effective methods to drive effector genes to Þxation in natural populations. The genetic and ecological issues to bring this last aim to fruition are formidable (Scott et al. 2002) Three questions should be addressed as part of a realistic assessment of the promise of genome sequencing and using releases of genetically modiÞed mosquitoes (GMM) to reduce malaria or other vector borne diseases. (1) Are we closer to any of the above stated goals as a result of the completion of the An. gambiae sequence? (2) Have we learned enough about mosquitoes, pathogens and the diseases they cause to allow us to provide a realistic assessment on the prospects for achieving our goals? (3) Can we address the high priority issues that will result in real progress toward our goals? These are not trivial issues since our answers to these questions are fundamental to the development of policy that will determine how research funds will be allocated.
The answer to the Þrst question is that yes we have made real progress and the An. gambiae sequence is a necessary start. It is an essential, invaluable tool that will require creativity and insight to make greater leaps in developing our understanding of the mosquito genome. The ability to use transgenic technology in experimental research is another tremendous tool for developing further information about the mosquito genome. It will also require creativity and insight in its use. There is a long way to go. The answer to the second question is yes and no. There has been enormous progress in all aspects of mosquito biology. There is a wealth of information on mosquito metabolism, biochemistry, physiology, ecology, genetics, population genetics, behavior, immunity and vectorpathogen-host interactions. Advances in understanding components of vector competence for many pathogens have been considerable and are reviewed elsewhere (Beerntsen et al. 2000) . However, despite all of the accumulated information, we have learned little that has been used effectively to control mosquito borne diseases. Consider the difÞculties facing the U.S. in efforts to understand and control West Nile virus. There has been progress identifying the U.S. West Nile virus transmission cycle, ampliÞcation hosts, the predominant mosquito vector species, new diagnostics, etc. However, there is precious little in the way of effective mosquito and disease control strategies that are much different than what would have been applied 30 yr ago. Indeed, there is little information at hand even to target control strategies to speciÞc high-risk regions, or to predict periods of highrisk transmission to humans. It is all too apparent that our understanding of the dynamics and impact of the diverse ecologies in the U.S. on West Nile transmission is rudimentary. The use of GMM in release strategies to interrupt transmission provide another possible new and very appealing strategy. However, is there sufÞcient biological knowledge to achieve success using this strategy? The challenge to disrupt these complex disease cycles is enormous. The third question is very difÞcult to answer and will be the subject of intense debate among vector biologists. This will be a contentious debate because scientists will always bring justiÞcations for supporting their own research programs. As a result there is always a conßict of interest in many assertions for the need for funding support, though we would like to believe this is not so. However, although one can agree with the importance and need for research into these complex issues, one can disagree with policy development that results in resources being devoted to any single well-sold program. Question three is the most vital and contentious of the questions concerning the future direction and impact of vector borne disease research. Which areas of research hold real promise to impact mosquito borne diseases? How much should be invested in supporting a particular program? What is the appropriate balance in the U.S. and international research portfolio to ensure that indeed there is real and useful progress in controlling vector borne diseases?
Where are we in achieving the three identiÞed goals of the WHO/TDR report? Are we ready to initiate Þeld work needed to pave the way for release of transgenic constructs or to use drive mechanisms to insert genes to Þxation into mosquito populations in nature? Here I am not as optimistic as the more exuberant proponents of this viewpoint are. There is no doubt that several technical aspects have been or shortly will be met. Transformation of mosquitoes, as a genetic engineering tool, has been successful and represents an extraordinary research tool at our disposal. Transformation or transgenic methodology has been extremely successful in studies investigating genetic mechanisms in Drosophila melanogaster Meigen and will provide similar opportunities in genetic studies in mosquitoes. However, caution is required in accepting that we know or will soon know about any "effector" gene on vector competence, vector viability, or other phenotypes, to consider using GMM and transgenic constructs in Þeld trials of any kind, on an island or some other similarly "isolated" site. Caution is needed to assure that we have the requisite knowledge to predict the outcome of any effector gene if it were "to be driven" into the genome of a vector species thereby encountering the sea of genetic variability and range of environments that the species will experience. I do not know of such information for any gene in any organism.
There are several signiÞcant, difÞcult, yet I hope surmountable problems ahead that must be addressed successfully to meet the three goals I have listed, and those proposed by the WHO/TDR Working group. Some of these problems have been mentioned elsewhere (see Beerntsen et al. 2000 for an excellent review of the details of vector competence and some associated difÞculties). The following will focus on some fundamental concerns about sequence information in general, the vagaries of translating this information to understanding the actual phenotypes of mosquitoes and how these phenotypes are involved in complex mosquito-pathogen-host systems. These concerns are essential considerations for those justifying their research proposals with promised goals, and for those charged with developing and evaluating research priorities and a balanced U.S. and international research portfolio.
Nucleotide Sequence and Phenotype
One geneÐ one enzyme is an important concept that is taught in introductory biology courses. This concept has been modiÞed into the one geneÐ one polypeptide concept. It remains an important concept, but also may contribute to an unfortunate reductionist view of phenotype and our ability to determine phenotype from sequence information. What have we learned about sequence, phenotypes, and organisms? There are numerous examples of sequence variation resulting in phenotypic variation. Of course all phenotypic variation is not the result of sequence variation. However, there is a tendency to brush aside environmental effects while focusing purely on the simplest aspect of the genetic basis for phenotypic variability, the impact purely of variation in the sequence of a single gene on phenotype. It is ironic that in the same issue of Science that presents the An. gambiae sequence, and the power of mapping phenotypes to speciÞc candidate genes, there is an article that also reviews a change from this paradigm in the Þeld of behavior genetics. The author concludes that identifying speciÞc genes for speciÞc behaviors has not been fruitful since behaviors result from a complex interaction between gene networks and multiple environmental factors impacting brain development, function and ultimately behavior (Hamer 2002) .
For discussion, I will focus on a single aspect of vector competence with which I have some familiarity, the aspect of vector competence that results in susceptibility of a mosquito vector to infection with a pathogen. This is the essential component of vector competence where the pathogen replicates in the mosquito vector before being transmitted to a subsequent host. Although my own expertise concerns arboviruses and mosquitoes, malaria is very similar. We know that for a mosquito to become infected with a pathogen, like malaria, the pathogen must cross the midgut to move from the infectious blood meal in its gut, to the hemocoel where it replicates, ultimately to infect the salivary glands and be passed to the next host upon a subsequent blood meal. A reductionist view of the genetic control of one aspect of this trait, crossing the midgut, might be that there is a speciÞc midgut receptor(s) for the pathogen that enables it to cross the midgut. Block these receptors or interfere with this process and one can reduce the mosquitoÕs competence for this pathogen. Several studies show the existence of receptors for pathogens, (Ludwig et al. 1996 , Xu et al. 1997 . However, does it follow that sequence information and the Þnd-ing of a single gene controlling a midgut receptor(s) implies that this same gene and its associated variation controls all receptor variation in nature, controls the phenotype of midgut accessibility in the same manner in each individual in the vector species? Hardly, and to quote Richard Lewontin on similar types of claims for sequence information and the search for single gene effects and phenotype, "it ainÕt necessarily so" (Lewontin 2000a) If one accepts the one geneÐ one polypeptide paradigm, and that this leads to the view of one geneÐ one phenotype, then our progress will indeed be easy. We can accept the promise that with the An. gambiae sequence information, the perfection of genetic transformation for genetic engineering of mosquitoes, and ultimately the technical development of a genetic driving mechanism, we are indeed close to our goals to understand genetic controlling mechanisms of vector mosquito phenotypes in very short order, and that disease intervention using GMM release strategies will follow closely behind.
"Life is like a box of chocolates, you never know which one you are going to get"ÑForrest Gump. There is an extraordinary complexity to the genome of all organisms that makes it very difÞcult to translate sequence information to actual phenotype. The sequence of any gene determines the speciÞc product the gene produces. However, the impact of that product on the resulting phenotype is inßuenced by surrounding genes, the position or location of the gene on the chromosome, random processes that cannot be predicted but impact subsequent processes, and external environmental factors. Predicting phenotypes from nucleotide sequence is very tricky business and we are not very good at it. One method that geneticists use to determine the impact of genetic variants on a phenotype is to use mutation, or gene substitution techniques to perturb a gene within a system to evaluate the consequences on phenotype. This is a wonderful experimental tool, and the rationale for the D. melanogaster program using P-element insertions to create a mutant gene in every one of the Ϸ3600 D. melanogaster genes that are essential for D. melanogaster adult viability (Spradling et al. 1999) . This method provides understanding of a genes role in governing function. However, the method focuses on large effects on phenotype though the primary controllers of variation in nature are often other genes with small individual impact. Problems in viewing the impact of a single gene or sequence on a phenotype in nature are that there can be many different mechanisms all able to provide the same phenotype. The organismsÕ genome itself, the genetic background, creates the environment that surrounds the speciÞc gene. Our ability to predict the phenotype of any gene in a range of environments including a range of genetic backgrounds is presently extremely difÞcult and rudimentary.
It is well known that single genes can provide an array of phenotypes because of different environments. The array of phenotypes that a single gene can provide is called the "norm of reaction" of the gene. Often mosquito and vector biologists turn to the enormous literature available from studies of species of Drosophila, principally D. melanogaster, as a model. The Drosophila literature was recently estimated to be greater then 60,000 published papers (Powell 1997) . Using PubMed as a gauge for publication activity, PubMed lists more then 40,000 Drosophila papers since 1963 compared with Ϸ20,000 published papers on Anopheles, Culex, and Aedes combined since that same year. Richard Lewontin (2000b) discussed the impact of environment using examples from D. melanogaster genetics, speciÞcally well characterized D. melanogaster mutations. For example, even well characterized D. melanogaster mutants like curly wing exhibit an array of different phenotypes likely because of some or all of the processes that impact phenotypic variation described above. The phenotype for curly wing is inßuenced by environmental conditions, like temperature and humidity, as well as the genetic background of the ßies. Another classic example of a geneÕs norm of reaction cited in many genetic textbooks is the number of D. melanogaster eye facets in relation to temperature resulting from different mutant genotypes at the Bar locus (Fig. 1) . Sequence information does not provide complete understanding or ability to predict the resulting phenotype because of other controlling factors in both the internal and external environments.
Unfortunately, we have less understanding of the norms of reaction for mosquito genes, for example speciÞc vector competence genes, though there are numerous studies showing the importance of internal and external environmental factors in determining phenotypes, including susceptibility to infection with a pathogen. The effects of external factors like temperature, diet, and pathogen variation on mosquito susceptibility to infection are well documented. Many studies show that increasing temperature results in greater susceptibility to many different arboviruses and other pathogens. However, the complexity of the impact of environmental variation with genetic variation remains under appreciated and not fully explored. Studies of susceptibility to infection of the biting midge, Culicoides sonorensis, with bluetongue virus, showed that the serotype of bluetongue virus had effects on the susceptibility to infection of speciÞc C. sononrensis strains and that the strains responded to different serotypes differently (Mecham and Nunamaker 1994) . The conclusion was that the norm of reaction for one strain for different serotypes did not predict the norms of reaction of another strain to these same serotypes. In this study, viral or pathogen variation was an important environmental factor in determining the phenotypic response of the genotype of a colony of insects. A 1986 yellow fever outbreak in Nigeria was caused by Ae. aegypti where only Ϸ7% of the vectors were capable of transmitting yellow fever virus under laboratory conditions (Miller et al. 1989 ). The authors believed that large numbers of mosquitoes made up for their low vector competence resulting in the epidemic. However, at the time, no information was available demonstrating that the low laboratory transmission frequency also occurred in nature. In retrospect, the vector competence norm of reaction was unknown and an equally likely explanation for the outbreak is that infection rates were higher under Þeld conditions then what was observed in the laboratory. Beerntsen et al. (2000) review studies showing that Anopheles vectors of malaria show norms of reaction in susceptibility to infection with different malaria variants. The norms of reaction of speciÞc vector competence genotypes have hardly been explored. Figure 2 shows a hypothetical norm of reaction of three vector competence genotypes in increasing temperature environments. This is a simple illustration where all three genes respond to temperature with a standard response, increasing with increasing temperature. However, as with eye facets in D. melanogaster, there is a genotype that has the poorest susceptibility at the lowest temperatures, but has the highest susceptibility of the three genotypes at the higher temperatures, i.e., a gene X environment interaction. Another way to portray the norm of reaction of a genotype is shown in Fig. 3 . Here the height of the cone shows the response of the "effector" gene, the corresponding phenotype, in each of ten different environments. If the phenotype represented here is susceptibility to infection with a pathogen represented by the height of the cone, then gene A genotypes are most susceptible in environment Þve and lose susceptibility in the extreme high or low environments. This could be temperature, diet, population density, humidity, etc., the array of environments that a species will encounter. Figure 4 adds complexity and might be viewed as a landscape for the norms of reaction of gene A when gene A is placed in the context of different genetic backgrounds, i.e., the sea of genetic variation at other loci it might encounter in the species. For example, consider the genetic background of An. gambiae, where S in Fig. 4 represents different An. gambiae chromosome inversions. This is an extreme example to illustrate the point that caution is needed in any attempts to spread a new gene through a species using a drive mechanism. Note that there are many genetic backgrounds and environments where gene A would be considered completely refractory. However, other environments and backgrounds will be encountered where gene A is highly susceptible. Currently we do not have a speciÞc mosquito candidate gene to consider for use as a model for a transgenic study to reduce the vector competence of a mosquito. More troubling is that there is little information on a research program that will be able to test the norm of reactions of such a gene to assure that the resulting phenotypes will be predictable and within the intended refractory range. There is little information for mosquitoes to begin to deÞne the range of genetic backgrounds (S1-S10 in Fig. 4 ) and the range of environments that impact a speciÞc gene ( Fig. 4; x-axis) is not deÞned. There is simply no information or program to address these very complex issues at this time.
To further illustrate the challenges of using transgenic release approaches to impact vector populations, consider a transgenic release of a single wellcharacterized gene into a D. melanogaster population as a proof of this concept. Among the most well characterized D. melanogaster genes is Adh. This gene produces the enzyme alcohol dehydrogenase. PubMed lists almost 500 publications on D. melanogaster Adh since 1968, equal to about half of all publications listed by PubMed for the entire An. gambiae species during the same period. Adh has been sequenced in nearly 40 different Drosophila species, and its genetic diversity has been studied in natural populations of several species. Most importantly there is a growing body of studies demonstrating the impact of variants of this gene on the phenotype and the adaptive signiÞcance of these variants (reviewed in Powell 1997) . Is there enough information on this very well characterized gene to predict the array of phenotypes that might be produced resulting from a transgenic release in nature, and the potential impact on Þtness variation in natural populations? As the following paragraph demonstrates, the answer is no.
One tool that Drosophila geneticists use to study the effect of speciÞc genes takes advantage of their ability to construct genetic strains where all of the individuals in the strain contain identical chromosomes. The individuals in such a strain are thus, genetically identical for all of the genes on the identical chromosomes. As a result, the speciÞc gene of interest can be substituted with variants to determine the impact on phenotype. This is a powerful technique. Drosophila researchers are well aware that the genetic background is part of the environment that has an impact on phenotype. Hence to target a speciÞc geneÕs impact, the genetic background to compare variant genes must be held constant. It is known that two Adh alleles, labeled F and S, differ in levels of activity and ability to detoxify alcohol. Adh is an important gene for Drosophila because these insects typically inhabit the alcohol rich habitats of rotting fruit, so alcohol detoxiÞcation is vital to survival. It is known that Adh activity in D. melanogaster is inßuenced by different genetic backgrounds. Aquadro et al. (1986) showed that the F and S alleles each had activity norms of reaction of ca. twoto threefold when placed in ßies with different second chromosomes, while these ßies were identical for all the other chromosomes. Therefore, second chromosome variation had an impact on the activity of both alleles, though F still had higher activity then S. Introducing D. melanogaster Adh alleles into another species supports the impact of genetic background. D. melanogaster has consistently higher Adh activity then D. simulans Sturtevant. Laurie et al. (1990) showed that D. simulans Adh genes had higher activity when placed into D. melanogaster, while D. melanogaster Adh genes had lower activity when placed in D. simulans. The genetic background that these genes were placed into had substantial effects on their activity. D. melanogaster Adh F alleles placed into the germline of the Mediterranean fruit ßy, Ceratitis capitata (Wiedemann), using the transformation vector Minos, resulted in variability in activity in just the 11 transgenic lines that were examined (Christophides et al. 2001 ). The authors attribute this variation to chromosomal position effects, though they present no information concerning other genetic and environmental factors. Though these studies demonstrate the inßuence of genetic background, the inßuence of environmental effects, interacting with the genetic effects is unknown. The studies were laboratory evaluations and therefore the range of environments was less then what will be encountered in nature. The ability to predict the phenotypic variation of an Adh transgene in the range of environments it will experience in nature is questionable for this well-characterized, well-studied gene. Would it have been prudent to use Adh for a transgenic release shortly after it was Þrst identiÞed as the gene producing alcohol dehydrogenase? Recall no such gene is yet available for vector competence. The goal of predicting the phenotypic response of a speciÞc gene in nature is a difÞcult challenge.
The impact of internal and external factors on gene expression is also illustrated in the development of transgenic approaches in mosquitoes. One of the methods to identify a transgenic mosquito is the use of a D. melanogaster construct, as a genetic part of the transgene, that supplies a missing enzyme which will change a white eye genotype caused by the absence of the enzyme, to normal color. Aedes aegypti mosquitoes are used that have white eyes because of a genetic mutation at the gene producing the enzyme. The transgene contains a copy of the D. melanogaster piece of DNA that if incorporated into the recipientÕs genome, supplies the enzyme and "rescues" white resulting in wild type mosquitoes with dark colored eyes. Therefore any transgenic mosquitoes can be detected visibly because these will have dark eyes in comparison to the nontransformed white eye mosquitoes. Figure 5 shows pictures of wild, white, and transformed mosquitoes. Typically the ability of the dark color rescue from white is extremely variable. The transgenic mosquitoes show phenotypic variation likely a result of a variety of the environmental issues already discussed, i.e., differences in the position of the insertion, unknown laboratory environmental factors, and likely genetic differences in the backgrounds of these laboratory ßies. In the genetically depauperate environment of the test colony, under the likely constrained environmental conditions of the laboratory environment, the phenotypic expression of the transgene is not predictable. The inability to produce site speciÞc, targeted insertion of the transgene is a major problem that will have to be overcome. Position effects produce phenotypic variation.
Another issue facing transgenic release strategies is also troubling. This is the possibility that there are many pathways or mechanisms in the same mosquito, or genetically identical mosquitoes leading to the phenotype. An analogy used elsewhere (Lewontin 2000a) is drawn from one of the most complex of human processes to understand, the biological processes involved in human thought. I can hold a picture of my mother in my mind as vivid in my mind as when she was alive 10 yr ago. One might assume that there are abundant, complex and interacting processes in my brain (at least I would like to think so)Ñneuron networks, chemicals, the likely by product of some other evolutionary processes that were important in human development. The sequence reductionist view is that all the components in this process ultimately stem from the information encoded in my DNA genome sequence, albeit likely very complex, with a complex interaction of these products. The phenotype here is a mental image. Does everyone use similar processes, neuronal pathways and interacting chemicals, similar sections, loci and genes in making mental images? Do we use similar pathways and processes, genes in the same image Þve minutes apart? Questionable. Would I use the same processes, genes, sequences, etc., as my identical twin in writing this manuscript?
Why should mosquitoes and vector competence be any different? Perhaps there is only one or very few processes in a species like An. gambiae that can be interfered with or interrupted that will transform a population or an entire species, and reduce its efÞ-ciency as a malaria vector. It may be likely that determining the impact of a sequence variant of a An. gambiae receptor gene for malaria in the midgut will provide understanding of the control of that trait in that strain of mosquitoes under the test conditions. It may also be possible that introduction of an antipathogen peptide, an immune factor, will interrupt pathogen development in the vector as is often proposed. However, it may be equally likely that the receptor, or immune factor is just one part of a large network of possibilities that are integral to the makeup of An. gambiae so that there are many opportunities to achieve the same susceptible phenotype in this vector.
Current efforts that view vector competence phenotypes as quantitative traits and use quantitative mapping searches to identify quantitative trait loci (QTL) are an important Þrst step toward identifying controlling mechanisms (Bosio et al. 2000; Severson et al. 1995 Severson et al. , 1999 . However, here too we are only at the beginning of the essential studies of mosquito genetic architecture. The Drosophila experience illustrates the complexity. As greater and greater precision has become available, more genetic complexity becomes apparent. Dilda and Mackay (2002) reported a total of 53 QTL affecting sensory bristle number in D. melanogaster, a far greater number then thought or observed in previous mapping studies. These authors note that it is unlikely this complexity is peculiar to only D. melanogaster, and that detection of such complexity will be very difÞcult in organisms not amenable to sophisticated genetic analysis. This is a difÞcult yellow brick road we are on.
Using Transgenic Mosquitoes for Population Replacement or Population Reduction
There is no doubt that the information from the An. gambiae genome sequence will be an asset for evaluating markers and for characterizing genetic variation and its meaning in laboratory experiments and in Þeld populations. It will also be an asset for similar studies in other mosquitoes because workers will extract and mine information from An. gambiae that is applicable and can be used in establishing homologous markers in these other species.
There is not nearly enough information to gauge the prospects for success for population replacement or population suppression using genetic means by the release, for example, of transgenic or GMM. For years the problem with the prospects for transgenic mosquitoes was purely a technical one in perfecting this technology that has been so useful in moving Drosophila genetics forward. I hope and expect that the technology will have a similar effect on vector genetics. Transgenic approaches are an essential tool to begin gene substitution and insertion experiments that were alluded to earlier that have been so successful in unraveling the impact of speciÞc genes and mechanisms controlling speciÞc phenotypes in species of Drosophila.
There is a long road of work ahead before transgenic release strategies will impact vector mosquitoes in nature and vector borne diseases like malaria. A great deal of work is needed before it will be safe for Þeld tests of candidate transgenic mosquitoes that impact any component of vector ability. Fundamental genetic issues remain that must be addressed if there is a hope for success. Caution is warranted to ensure that we avoid too much reliance on reductionist views of the impact of speciÞc genes on the phenotype. There is far too little information available concerning speciÞc mosquito genes, norms of reaction, and the ability to predict a phenotype in the environments a gene is likely to encounter in the sea of genetic variation within a species, like An. gambiae in nature. The vagaries of assessing impact on phenotype are evident and are amply illustrated in the initial work producing transgenic Ae. aegypti. There is far too little information on the structural organization of the An. gambiae genome, and the genome of other vectors, in natural Þeld populations. The inßuence of genetic polymorphism is unknown, the inßuence of chromosome structure is unknown. What of the impact of the relatively well studied and ubiquitous An. gambiae chromosome inversions on phenotypic variation of surrounding genes? Although there is evidence of their effects on Þtness, the effect of these inversions on the genome and genetic architecture of the species is not understood.
The challenges ahead for developing a successful release of transgenic GMM are daunting. In addition to the challenges in predicting consequences on the phenotype of the trait, there is the challenge to understand the effect of a transgene on the Þtness of the transformed mosquito, and the stability of the transgene construct once it is released into nature. Fitness is determined relative to the particular environment and genetic background. Hence any study of Þtness effects using laboratory trials, artiÞcial cage trials, whether in the laboratory or the Þeld, may provide little information in the context of naturally occurring variation in nature. Fitness evaluations, even under controlled laboratory conditions, are unable to detect small Þtness differences with precision, although such small differences will impact the evolution of the population. Will "effector" genes have large or small effects on Þtness? If there are large detectable negative effects, then there will be problems in driving the gene into the population. If the effects are too small to be detected, then the outcome of the release will be problematic and a throw of the dice. The Þnding of negative Þtness effects in transformed Anopheles stephansi Liston in the laboratory (Catteruccia et al. 2003) illustrates the difÞculties. Would the Þnding of no Þtness effects under these test conditions have been valuable in assessing Þtness in nature? This is difÞcult to answer because the natural environment and genetic variation in nature is not deÞned. Studies to evaluate the stability of transgene constructs in populations are in their infancy. Although a P-element transgene containing D. melanogaster Adh did spread when introduced into several laboratory populations, the transgene experienced an ca. threefold increase in size as it spread, some of the Adh genes still encoded active product, others did not (Meister and Grigliatti 1993) . Any changes in transgene stability would open up new possibilities for changes in the norm of reaction of the associated gene and the effect of the gene on Þtness.
One can question the merits of the goal to use transgenic releases to introduce refractory genes into mosquito populations on several levels. First there is a lack of sufÞcient knowledge about phenotypic variation that would occur because of the release and the possibility of unintended consequences. Second, there is a lack of information on the likelihood of the transgene having negative effects on Þtness making establishment more problematic. We are only beginning to explore the possibilities for other strategies that might prove more realistic? Research on pathogen development in the mosquito using transgenics, genome sequence and other tools, will determine processes that prevent the pathogen from having a substantial negative effect on the vector. Can genes be driven into An. gambiae mosquitoes that result in the equivalent of mosquito disease as a result of the infection? LetÕs give malaria, dengue, West Nile, etc., to the mosquitoes! Death before subsequent blood feeding would interrupt transmission and would impact reproduction. However, only the small proportion of mosquitoes actually infected would be impacted, thereby having a small negative impact on Þtness. Of course the same caveats and issues arise. What is the norm of reaction? Does the gene have epistatic effects on Þtness? The possibilities for new strategies are endless.
What could one expect from the release into a natural An. gambiae population of a speciÞc vector competence gene, incorporated into GMM that is purported in the laboratory to reduce An. gambiae vector competence for a strain of Plasmodium falciparum? This is a complex box of chocolates.
Conclusions
This is an exciting time in vector biology. The An. gambiae genome sequence and transgenic techniques provide new tools to move forward answering some of the issues that are raised here. Many of these issues will be addressed and those that now seem so formidable might, with time and creativity, be overcome. However, it is vital that research priorities are developed to achieve realistic goals. For example, how much of our research investment should be put into perfecting and testing difÞcult to achieve genetic drive mechanisms? How much investment should be placed into a search for candidate genes solely for use in transgenic mosquito release strategies without accompanying greater understanding of the complexities of the phenotype that is the intended target? More generally, how much investment can we afford in any one area, which may be to the detriment of research in another area that will be essential to reach intended goals? What are the research priorities that will fulÞll the promise and potential of the genome sequence and transgenic methods and will also provide some direct impact on meeting immediate issues like mitigating the impact of West Nile virus in North America? It is not unreasonable to continue to demand that proposed research projects provide realistic expectations for meeting promised goals, including addressing some of the concerns raised here. We are at the very beginning of the use of the An. gambiae sequence and the use of transgenic approaches in investigations of all aspects of mosquito biology These important issues require investment. Some other avenues may have greater more immediate impact on malaria and disease control. The three goals I have listed above remain valid and appropriate subjects meriting support. For example, studies that characterize naturally occurring genetic variation in Þeld populations of vectors controlling traits that are important to mosquito life history, insecticide resistance, integrated pest management (IPM) resistance, vector competence and capacity will help target mosquito and disease control efforts and resources to the most dangerous populations and at the optimal periods to achieve maximum impact. We can provide essential information to improve the efÞciency, effectiveness and propriety of mosquito and disease control. Characterizing vector genetic variation, norms of reactions, etc., is essential to assess the danger of speciÞc vector populations. Such research requires the genetic studies using genome sequence and transgenic approaches as part of experiments, coupled with Þeld and ecological studies to assess functional signiÞcance. Information on mosquito-pathogen-host interactions will provide new control strategies that could include using environmental factors to mitigate disease risk. Instead of focusing on trying to change the genes in mosquito populations, there may be other simple, cost-effective environmental approaches that also impact phenotypic response. We have only begun to scratch the surface of the possibilities that will result from characterizing genetic control mechanisms. Knowledge of norms of reaction can provide new opportunities. New approaches, i.e., the use of bednets, DEET, source reduction, water storage uses, could also impact the norms of reaction of vector competence and capacity. These approaches can work now and new research on other strategies will improve on their impact. We will continue to develop new strategies, and sift through creative research proposals, many of which will hold great promise and potential. The issues I have raised lead me to be skeptical about the search for speciÞc refractory genes, molecules or mechanisms only for the purpose of transgenic release strategies. The mosquito replacement goal using GMM is just one limited view of the potential for impacting vector borne disease that has been laid at our door. I am very high on the use of sequence information and transgenic approaches to learn more about mosquito biology to improve the prospects for all types of disease control strategies, including genetic control of vectors. I am convinced that this information is essential to improving mankindÕs ability to realistically control mosquito borne diseases.
The dreams to characterize mosquitoes and their role in mosquito borne diseases to interrupt mosquito borne disease transmission with environmentally efÞcient, effective and targeted control strategies are valid. Genome sequence information and transgenic approaches will provide many opportunities for creative research that will result in new control strategies. This will require time, investment, and realistic goal setting.
